@FierceMedDev: Popular yesterday: For J&J, no device growth without Synthes. Article | Follow @FierceMedDev
@MarkHFierce: The device tax has already cost the industry $1 billion. Editor's corner | Follow @MarkHFierce
@DamianFierce: Will all that M&A help Abbott turn its medical device sales around? More | Follow @DamianFierce
> Illumina ($ILMN) has inked a deal with Boston's Pathogenica to co-market the company's HAI BioDetection kit in Asia. More
> Covidien ($COV) has launch two global trials to evaluate its Stellarex drug-coated balloon, designed to treat peripheral artery disease. Item
> In a blog post, two FDA medical device ombudsmen explain how the agency handles complaints and disputes between the FDA and the industry it regulates. Story
> RTI Biologics has secured a $50 million private placement from Water Street Healthcare Partners, cash that will fund its $130 million buyout of Pioneer Surgical Technologies. News
> Ceterix Orthopaedics has launched its NovoStitch technology in the U.S., following a $19.5 million funding round in January. Article
> Massachusetts' Cognoptix has developed an eye test it says can detect beta amyloid deposits to identify Alzheimer's disease patients. Report
Biotech News
@FierceBiotech: Popular: Is this the NIH Francis Collins wanted to create? Editor's corner | Follow @FierceBiotech
@JohnCFierce: GSK China official: We inflated conference costs, handed out bribes, pocketed cash and upped drug prices. More | Follow @JohnCFierce
@RyanMFierce: Bioinformatics buy bolsters Life's diagnostics pact with Merck Serono. Report | Follow @RyanMFierce
@EmilyMFierce: Animal studies produce many false positives. More | Follow @EmilyMFierce
> Buzz: Pfizer prowls Onyx auction block as bidding looms. Report
> Sequella scouts $38M round after nabbing Pfizer antibiotic. Article
> Lundbeck, Otsuka tout improved cognition in mid-stage Alzheimer's study. More
Pharma News
@FiercePharma: More tit-for-tat in Vivus proxy fight: FMC sues over meeting delay. $VVUS didn't like scoreboard, says Colin. Story | Follow @FiercePharma
@EricPFierce: FDA says Cispharma didn't do enough to make sure blood tissue didn't get into drugs when worker injured. Article | Follow @EricPFierce
@CarlyHFierce: NICE nixes Pfizer's CML drug Bosulif. Article | Follow @CarlyHFierce
> Novartis ex-chair Vasella nets new $5.2M exit package. Story
> Teva reveals CEO pay secret: Levin collected $4.1M in 2012. Article
Drug Delivery News
@MichaelGFierce: Rexahn snags nanotech platform for cancer drug delivery. Article | Follow @MichaelGFierce
> CalTech team combines two breast cancer drugs using nanoparticles. Report
> Math models tailor drug delivery using patient DNA. Story
> Melbourne team concocts self-assembling, nanoengineered drug delivery tech. Article
> York students eye crowdfunding for nanoparticle cancer patch treatment work. Item
> Oramed raising $4.6M for oral insulin trial. News